Control of blood glucose level in a diabetic patient with a glucometer. – SIMPSON33 / ISTOCK – ARCHIVE
MADRID, 3 Dec. (EUROPA PRESS) –
Up to 40 percent of the income of people with diabetes in Internal Medicine has its origin in a cardiovascular disease, either due to heart failure, in 20 percent of cases, or stroke, ischemic heart disease or peripheral arterial disease; as announced by the First Vice President of the Spanish Society of Internal Medicine (SEMI), Dr. Juana Carretero.
This is what the expert said during her speech at the round table ‘Cardiometabolic risk: Where does it start and where does it end?’, Which was held in the framework of the 41st SEMI Virtual Congress, with the collaboration of Novo Nordisk and the participation of experts in the field.
In this regard, insulin resistance “is one of the main determinants of cardiometabolic risk, along with low-grade inflammation, elevated blood pressure, or altered blood lipid levels (dyslipidemia).” , has abounded the doctor of the Service of Internal Medicine of the University Clinical Hospital of Valencia, the professor Josep Redon. “All sound are factors that promote the development of cardiovascular disease, kidney disease and type 2 diabetes,” he added.
Therefore, type 2 diabetes is related to cardiometabolic syndrome, so there is no single mechanism by which sugar increases the risk of suffering a cardiovascular event. In general, these are people with abdominal obesity, based on an inherited genetic risk who, if they also have a sick lifestyle, usually develop, in addition to diabetes, hypertension and dyslipidemia. All this affects the blood vessels, favoring the appearance of atheroma plaque, which causes the blood flow to become less fluid and the vessels may end up clogging.
Thus, there are circumstances that, as Dr. Carretero points out, mean that “more than half of the cases of complications associated with diabetes are discussed in cardiovascular diseases, and are producing hospital admissions, loss of life expectancy or mortality “.
EARLY AND ACCURATE CONTROL
Experts have agreed that it is “fundamental” to act accurately from the beginning, when there are risk factors for having this cardiometabolic syndrome, as is the case with diabetes. In this regard, Dr. Carretero has insisted on the need to move towards precision medicine in the treatment of type 2 diabetes. “Have a comprehensive approach to the patient and we know that there are several intermediate metabolic conditions that they make a person develop this type of diabetes, so we have to intend to combine these conditions with genetic alterations to give them the best possible treatment. “
Likewise, Dr. Redon has recorded that “in fetal life there are already epigenetic changes that establish a whole series of alterations that will be conjugated with other elements of daily life, such as diet or physical activity.” He added that “everything favors overweight, obesity and, consequently, the development of cardiometabolic risk. Therefore, this risk may be present from childhood and it is” key “to control and treat it in a adequate.
BENEFITS OF CARDIOMETABILITY TREATMENTS
With regard to treatment, Dr. Carretero has drawn attention to the availability of very good cardiometabolic therapeutic options. And, as the doctor of the Internal Medicine Service of the Regional University Hospital of Málaga, María Dolores López, points out, “micro and macro vascular risk is one of the pillars of morbidity and mortality of people with diabetes in the medium and long term. , have drugs such as glucagon analogues similar to type 1 glucagon, such as semaglutide, which significantly reduces blood glucose levels, while helping in weight control and makes you want the risk of a serious cardiovascular episode , is vital for these patients. “